| Title |
Author |
Type |
Date |
Words |
| Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer. |
|
|
May 30, 2012 |
1478 |
| Exelixis Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer. |
|
|
May 30, 2012 |
851 |
| Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer. |
|
|
May 23, 2012 |
1130 |
| New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer. |
|
|
May 23, 2012 |
1263 |
| Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer. |
|
Clinical report |
May 16, 2012 |
2044 |
| Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma. |
|
|
May 15, 2012 |
959 |
| In 2020, FOLFIRI Plus Ramucirumab Will Earn Decision Resources' Proprietary Clinical Gold-Standard Status for the Second-Line Treatment of Metastatic Colorectal Cancer. |
|
|
May 8, 2012 |
770 |
| German Federal Regulator Confirms Additional Benefit of Anti-cancer Agent Halaven(R) for Metastatic or Locally Advanced Breast Cancer. |
|
|
Apr 24, 2012 |
1005 |
| For the Treatment of Advanced Non-Small-Cell Lung Cancer, Medical Oncologists Report That They are Rapidly Adopting the ALK-Positive Test into Their Treatment Practices to Identify Appropriate Patients for Xalkori (crizotinib). |
|
|
Apr 16, 2012 |
681 |
| Docetaxel Dominates First-Line Metastatic Castrate-Resistant Prostate Cancer Treatment, But Total Patient Share of Zytiga and Jevtana Reach Nearly 50 Percent in the Second and Third-Line Settings According to Surveyed Physicians. |
|
Clinical report |
Apr 3, 2012 |
732 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2170 |
| Germ cell tumor metastatic to the oral cavity. |
Lee, Luis; Oppenheimer, Randy; Jayaram, Lakshmi |
Case study |
Apr 1, 2012 |
1161 |
| Study Establishes Safety and Clinical Benefit of SIR-Spheres[R] microspheres in Treating Metastatic Liver Tumors in Patients who Failed Systemic Chemotherapy. |
|
Clinical report |
Mar 27, 2012 |
615 |
| DFINE Introduces STAR Tumor Ablation System at SIR 2012. |
|
|
Mar 22, 2012 |
937 |
| Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas. |
|
|
Mar 20, 2012 |
1083 |
| DFINE Announces First U.S. Patient Treated with the STAR Ablation System. |
|
|
Mar 14, 2012 |
1048 |
| BioSante's Prostate Cancer Vaccine Resulted in Stable Disease in Over 50% of Patients in Newly Published Study. |
|
Clinical report |
Mar 5, 2012 |
955 |
| The effects of tumor size, degree of differentiation, and depth of invasion on the risk of neck node metastasis in squamous cell carcinoma of the oral cavity. |
Haksever, Mehmet; Inancli, Hasan Mete; Tuncel, Umit; Kurcuoglu, Sefik Sinan; Uyar, Melek; Genc, Omer |
Report |
Mar 1, 2012 |
4219 |
| Plexxikon Announces European Approval of Zelboraf[R] for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma. |
|
|
Feb 20, 2012 |
1467 |
| Prostate cancer patients get access to breakthrough treatment. |
|
|
Feb 20, 2012 |
375 |
| Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis[logical not]" Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma (mRCC). |
|
Clinical report |
Feb 4, 2012 |
711 |
| Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving Paclitaxel and review of drug-induced pyogenic granulomas adjacent and beneath the nail. |
Paul, Laura J.; Cohen, Philip R. |
Clinical report |
Feb 1, 2012 |
3364 |
| Novel therapies for the treatment of metastatic melanoma. |
Chouake, Jason; Friedman, Adam |
Report |
Feb 1, 2012 |
2290 |
| Managing lymphoedema in palliative care patients: a collaborative approach to the care of palliative patients with lymphoedema has had encouraging results. |
Walker, Jackie; Thomson, Mary |
Report |
Feb 1, 2012 |
1945 |
| Despite No Current Approval of Janssen's Zytiga in Asymptomatic/Minimally Symptomatic MCRPC, 31% of Surveyed Physicians Report Decreased Use of Dendreon's Provenge Because Zytiga is Available for Later Lines of Treatment. |
|
|
Jan 16, 2012 |
550 |
| Eisai Inc. Receives J-Code from CMS for Halaven[R] (eribulin mesylate) Injection. |
|
|
Jan 3, 2012 |
950 |
| New Randox molecular diagnostic test enables selection of CRC patients for anti-EGFR therapy. |
|
Brief article |
Jan 1, 2012 |
240 |
| Celldex Completes Accrual of CDX-011 Phase 2b "EMERGE" Study in Advanced Breast Cancer. |
|
|
Dec 21, 2011 |
1185 |
| ResearchMoz: Optimizing Treatment for Bone Metastases in Patients With Advanced Cancers. |
|
|
Dec 13, 2011 |
1062 |
| Exelixis' Cabozantinib Shows Encouraging Clinical Activity in Patients With Metastatic Breast Cancer. |
|
|
Dec 7, 2011 |
1301 |
| War on cancer. |
Moss, Ralph |
|
Dec 1, 2011 |
2436 |
| Primary lung cancer presenting as metastasis to the big toe. |
Nicholson, S.; Mohamed, I.; Tahir, A.; Antunes, G. |
Case study |
Dec 1, 2011 |
1244 |
| FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer. |
|
|
Nov 18, 2011 |
1984 |
| Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC. |
|
|
Nov 12, 2011 |
2085 |
| Exelixis' Cabozantinib Phase 2 Data Demonstrate Reduction in Bone Pain and Narcotic Analgesic Use in Patients with Previously Treated mCRPC. |
|
|
Nov 12, 2011 |
1833 |
| Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival. |
|
|
Oct 26, 2011 |
1298 |
| Serono Symposia International Foundation (SSIF) : Multidisciplinary Approach to Managing Liver Metastases From Colorectal Cancer: Focus on Resectability and Combined Chemotherapy and Surgery-the 'OncoSurge' Approach. |
|
|
Oct 20, 2011 |
528 |
| Topline Results: A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. |
|
Clinical report |
Sep 30, 2011 |
802 |
| Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival. |
|
|
Sep 28, 2011 |
1097 |
| Biocept Publishes on Mechanics and Performance of Its OncoCEE(TM) Platform for Circulating Tumor Cells (CTCs) in Cancer Patients. |
|
|
Sep 28, 2011 |
378 |
| Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer. |
|
|
Sep 27, 2011 |
1445 |
| Zytiga Approved in the European Union for Metastatic Castration-Resistant Prostate Cancer. |
|
|
Sep 7, 2011 |
1582 |
| Pigmentary changes in a patient treated with imatinib. |
Balagua, Yevgeniy; Pulitzer, Melissa P.; Maki, Robret G.; Myskowski, Patricia L. |
Case study |
Sep 1, 2011 |
2750 |
| Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System. |
|
|
Sep 1, 2011 |
1303 |
| Interest High for Novel Treatment Options in Development for Metastatic Breast Cancer, According to Oncology Tracking Study by GfK HealthCare. |
|
|
Aug 24, 2011 |
950 |
| Symphogen Announces Initiation of Phase 2 Trial of Sym004 EGFR Antibody Mixture in Patients with Squamous Cell Carcinoma of Head and Neck Cancer. |
|
|
Aug 23, 2011 |
698 |
| Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System. |
|
Clinical report |
Aug 22, 2011 |
1238 |
| Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome. |
|
Clinical report |
Aug 9, 2011 |
1435 |
| Management of lateral cervical metastases in papillary thyroid cancer: patterns of lymph node distribution. |
King, J. Michael; Corbitt, Christian; Miller, Frank R. |
Clinical report |
Aug 1, 2011 |
2360 |
| Zytiga Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration Resistant Prostate Cancer. |
|
Disease/Disorder overview |
Jul 22, 2011 |
1364 |
| NCCN Breast Cancer Panel Reaffirms Current Position and Recommendation Regarding the Use of Bevacizumab in Metastatic Breast Cancer. |
|
|
Jul 19, 2011 |
625 |
| Phase 3 Trial of ZALTRAP(TM) (aflibercept) in Advanced Prostate Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee. |
|
|
Jul 7, 2011 |
1380 |
| ACORN Research Reports Positive Findings of Phase 2b Metastatic Breast Cancer Trial at ASCO. |
|
Clinical report |
Jun 30, 2011 |
612 |
| Alternative Pain Therapy for Breast, Prostate and Lung Cancer. |
|
|
Jun 28, 2011 |
365 |
| Sphenoid sinus metastatic lesion from a pyriform fossa squamous cell carcinoma. |
Barrett, G.; Espeso, A.; Hickey, S.A. |
Case study |
Jun 8, 2011 |
1046 |
| Exelixis' Cabozantinib Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Jun 6, 2011 |
2855 |
| Targeted drug-combo shows promise in treating metastatic melanoma. |
|
|
Jun 4, 2011 |
178 |
| Exelixis' Cabozantinib Demonstrates Encouraging Clinical Activity in Patients with Metastatic Ovarian Cancer. |
|
|
Jun 4, 2011 |
1659 |
| Celgene and Acceleron Initiate Phase 2/3 Study of ACE-011 (sotatercept) to Treat Chemotherapy-Induced Anemia in Patients with Lung Cancer. |
|
|
Jun 2, 2011 |
869 |
| Johnson & Johnson's Zytiga is Forecasted to Earn Peak Year Sales of $910 Million for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. |
|
|
Jun 2, 2011 |
503 |
| Recent developments in kidney cancer. |
Leveridge, Michael J.; Jewett, Michael A. S. |
Clinical report |
Jun 1, 2011 |
8599 |
| A biopsy diagnosis? clinical clues and patterns to help distinguish cutaneous metastases: Part I of II. |
Blecher, Karin; Friedman, Adam |
Report |
Jun 1, 2011 |
3461 |
| Does surgery improve survival in stage IV breast cancer? |
Khan, Seema; Cady, Blake |
|
Jun 1, 2011 |
1361 |
| Abiraterone Acetate Significantly Improves Overall Survival of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer. |
|
Clinical report |
May 25, 2011 |
1634 |
| Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA(TM) (abiraterone acetate). |
|
Clinical report |
May 25, 2011 |
1516 |
| Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care. |
|
|
May 19, 2011 |
622 |
| CTC blood test most 'powerful predictor' of metastatic breast cancer. |
|
|
May 19, 2011 |
260 |
| Denosumab May Prolong Metastasis-Free Survival in Men with High-Risk Prostate Cancer. |
|
|
May 17, 2011 |
716 |
| Eisai's Eribulin (Halaven(R)) Receives Swissmedic Approval for use in Locally Advanced and Metastatic Breast Cancer. |
|
|
May 17, 2011 |
1690 |
| First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders. |
|
|
May 10, 2011 |
927 |
| Scientists discover protein that can halt spread of breast cancer. |
|
|
May 5, 2011 |
325 |
| Uveal tract melanoma: referral refinement part 1 course code: C-15795 O/D. |
Cohen, Victoria; Papastefanou, Vasilios P. |
Disease/Disorder overview |
Apr 8, 2011 |
2906 |
| T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial. |
|
|
Apr 7, 2011 |
618 |
| Amgen to Appeal CHMP Opinion on Vectibix (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe. |
|
|
Mar 30, 2011 |
2434 |
| Amgen to Appeal CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe. |
|
|
Mar 30, 2011 |
2354 |
| Halaven(TM) (Eribulin) Receives European Commission Approval for Advanced Breast Cancer. |
|
|
Mar 22, 2011 |
1418 |
| Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in Previously-Untreated Patients with Metastatic Melanoma. |
|
|
Mar 21, 2011 |
259 |
| Amgen Statement on CHMP Opinion on Vectibix (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer. |
|
|
Mar 18, 2011 |
2557 |
| Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer. |
|
|
Mar 18, 2011 |
2469 |
| Active Surveillance Monitoring More Stringent in Updated NCCN Guidelines for Prostate Cancer. |
|
|
Mar 14, 2011 |
1484 |
| New Therapies for Metastatic Disease Addressed in Updated NCCN Guidelines for Breast Cancer. |
|
Disease/Disorder overview |
Mar 10, 2011 |
1271 |
| The Lancet Publishes Results from Pivotal Study of Eisai's Halaven[TM] (Eribulin Mesylate) Injection in Patients with Late-Stage Metastatic Breast Cancer. |
|
Clinical report |
Mar 2, 2011 |
1637 |
| Study Published in the Lancet Shows Eisai's Halaven(TM)(Eribulin) Significantly Improves Overall Survival Compared With Current Treatments in Heavily Pre-Treated Metastatic Breast Cancer. |
|
|
Mar 2, 2011 |
1508 |
| Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine. |
|
|
Feb 18, 2011 |
855 |
| Cabozantinib (XL184) Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Castration-Resistant Prostate Cancer. |
|
|
Feb 17, 2011 |
2414 |
| Mechanism involved in breast cancer's spread to bone uncovered. |
|
|
Feb 4, 2011 |
372 |
| LILLY (ELI) & COMPANY - Necitumumab Trial DMC. |
|
|
Feb 3, 2011 |
2864 |
| For the Treatment of Metastatic Castrate Resistant Prostate Cancer, Surveyed Oncologists and MCOs Are Highly Satisfied with the Safety and Tolerability of Dendreon's Provenge When Compared to Other Currently Available Therapies. |
|
|
Feb 2, 2011 |
788 |
| A biobehavioral perspective on depressive symptoms in patients with cerebral astrocytoma. |
Starkweather, Angela R.; Sherwood, Paula; Lyon, Debra E.; McCain, Nancy L.; Bovbjerg, Dana H.; Broad |
Clinical report |
Feb 1, 2011 |
7872 |
| Dasatinib in treating patients with unresectable or metastatic squamous cell skin cancer or RAI Stage 0-1 chronic lymphocytic leukemia. |
|
Brief article |
Feb 1, 2011 |
170 |
| Sorafenib and temsirolimus in treating patients with metastatic, recurrent or unresectable melanoma. |
|
Brief article |
Feb 1, 2011 |
254 |
| Dasatinib in treating patients with locally advanced or metastatic mucosal melanoma, acral melanoma, or solar melanoma that cannot be removed by surgery. |
|
Brief article |
Feb 1, 2011 |
146 |
| Patients and Physicians Rally on Capitol Hill to Tell Congress YES! We Can Beat Liver Tumors. |
|
|
Jan 31, 2011 |
603 |
| Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer. |
|
|
Jan 27, 2011 |
1230 |
| North American Seminars, Inc. Introduces a New Physical Therapy Continuing Education Course, Advanced Management of Breast Cancer Rehabilitation. |
|
|
Jan 26, 2011 |
776 |
| Eisai's Halaven(TM) (Eribulin) Receives CHMP Positive Opinion for use in Metastatic Breast Cancer. |
|
|
Jan 21, 2011 |
1515 |
| 4SC Announces First Patient Dosed in Phase I/II SHORE Study in KRAS-Mutant Colorectal Cancer Patients with Resminostat. |
|
|
Jan 20, 2011 |
1517 |
| ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients with Metastatic Soft-Tissue or Bone Sarcomas in the Phase 3 SUCCEED Trial. |
|
|
Jan 18, 2011 |
1089 |
| Metastatic lesions of the proximal femur. |
Doung, Yee-Cheen; Kenan, Samuel; Rapp, Timothy |
Disease/Disorder overview |
Jan 1, 2011 |
3376 |
| Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer. |
|
|
Dec 20, 2010 |
1363 |
| Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States. |
|
|
Dec 16, 2010 |
2611 |
| XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer. |
|
|
Dec 13, 2010 |
2042 |
| Pomegranate juice could be key to new cancer therapies. |
|
|
Dec 13, 2010 |
291 |
| Circulating tumour cells in blood up death risk in early-stage breast cancer patients. |
|
|
Dec 11, 2010 |
303 |
| ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer. |
|
|
Dec 10, 2010 |
998 |
| Bisphosphonate-associated osteonecrosis of the jaw. |
Ferrara, Mark G. |
Case study |
Dec 1, 2010 |
2078 |
| 35th Congress of the European Society for Medical Oncology (ESMO): October 8-12, 2010, Milan, Italy. |
Alfa-Wali, Maryam; Sharma, Anand |
Conference notes |
Dec 1, 2010 |
2747 |
| Radiation therapy of a malignant melanoma in a thick-billed parrot (Rhynchopsitta pachyrhyncha). |
Guthrie, Amanda L.; Gonzalez-Angulo, Carlos; Wigle, William L.; deMaar, Thomas W. |
Clinical report |
Dec 1, 2010 |
2588 |
| Provectus Pharmaceuticals Reports Continued Progress in Compassionate Use Program of PV-10 for Non-Visceral Cancers. |
|
|
Nov 23, 2010 |
850 |
| Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC). |
|
|
Nov 19, 2010 |
1799 |
| Exelixis Reports Promising Interim Data from Patients with Castration-Resistant Prostate Cancer Treated with XL184. |
|
|
Nov 18, 2010 |
2034 |
| Dendreon Announces MEDCAC Panel Reviewed PROVENGE Evidence. |
|
|
Nov 17, 2010 |
880 |
| Genta Initiates Trial with Tesetaxel as First-Line Chemotherapy for Women with Metastatic Breast Cancer. |
|
|
Nov 8, 2010 |
1335 |
| Published Results Show Denosumab Superior to Zometa in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer. |
|
Clinical report |
Nov 8, 2010 |
2561 |
| Differential diagnosis of pediatric tumors of the nasal cavity and paranasal sinuses: a 45-year multi-institutional review. |
Holsinger, F. Christopher; Hafemeister, Adam C.; Hicks, M. John; Sulek, Marcelle; Huh, Winston W.; F |
Report |
Nov 1, 2010 |
3091 |
| ARIAD Announces Interim Results from Randomized Phase 2 Trial of Oral Ridaforolimus in Advanced Endometrial Cancer. |
|
Clinical report |
Oct 25, 2010 |
955 |
| Improving support for secondary breast cancer patients; To mark Secondary Breast Cancer Awareness Day, Dr Jacinta Abraham, consultant clinical oncologist at Velindre Cancer Centre, explains how health professionals in the area are coming together to lend support to patients with secondary breast cancer. |
|
|
Oct 18, 2010 |
734 |
| NCCN Guidelines for Breast Cancer Updated; Bevacizumab Recommendation Affirmed. |
|
|
Oct 18, 2010 |
657 |
| Abiraterone Acetate Significantly Improved Overall Survival for Patients With Metastatic Advanced Prostate Cancer. |
|
Clinical report |
Oct 11, 2010 |
1944 |
| Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer. |
|
Clinical report |
Oct 11, 2010 |
1845 |
| Eisai's Eribulin Mesylate Maintains Overall Survival Benefit in Patients With Metastatic Breast Cancer, Irrespective of Tumour Hormone Receptor Status. |
|
Clinical report |
Oct 10, 2010 |
1842 |
| New therapy shows promising result for HER2-positive metastatic disease. |
|
|
Oct 9, 2010 |
323 |
| DFine Announces FDA 510(k) Clearance of New Radiofrequency Ablation System for Metastatic Spinal Lesions. |
|
|
Oct 4, 2010 |
588 |
| Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients. |
|
Financial report |
Oct 1, 2010 |
1135 |
| MAGE-A3 antigen-specific cancer immunotherapeutic in patients with progressive metastatic cutaneous melanoma. |
|
Brief article |
Oct 1, 2010 |
219 |
| Study of GSK2132231A antigen-specific cancer immunotherapeutic in patients with inoperable metastatic cutaneous melanoma. |
|
Brief article |
Oct 1, 2010 |
110 |
| Teva and OncoGenex Announce Initiation of Second Phase 3 Trial of Custirsen in Men with Metastatic Prostate Cancer. |
|
|
Sep 30, 2010 |
1756 |
| Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer. |
|
|
Sep 30, 2010 |
771 |
| India Approves Advaxis Trial in Cervix Cancer. |
|
|
Sep 22, 2010 |
1056 |
| The Karmanos Cancer Center One of the First in Michigan to Use PROVENGE, the New FDA-Approved Drug for Advanced Prostate Cancer. |
|
|
Sep 15, 2010 |
943 |
| Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria. |
|
Clinical report |
Sep 9, 2010 |
648 |
| Plexxikon Publishes PLX4032 Phase 1 Data Demonstrating 81 Percent Response Rate in Metastatic Melanoma Patients in the New England Journal of Medicine. |
|
|
Aug 25, 2010 |
1071 |
| Study Finds Palliative Care Prolongs Life in Cancer Patients. |
|
Clinical report |
Aug 20, 2010 |
913 |
| Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy. |
|
Clinical report |
Aug 19, 2010 |
1175 |
| Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy. |
|
|
Aug 19, 2010 |
622 |
| Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial. |
|
Financial report |
Aug 11, 2010 |
2315 |
| New Cancer Nonprofit Competing for $50,000 Grant from Pepsi. |
|
|
Aug 11, 2010 |
479 |
| Primary testicular mucinous neoplasms: case report and literature review. |
Elliott, Jason E; Klein, Julianne R.H.; Drachenberg, Darrel E |
Case study |
Aug 1, 2010 |
2634 |
| The Cancer Profile and its clinical applications. |
Schandl, Emil K. |
Report |
Aug 1, 2010 |
2460 |
| A rare case of mistaken identity: metastatic hepatocellular carcinoma to the nose. |
Lee, G.K.; Lorenz, H.P.; Mohan, S.V. |
Case study |
Aug 1, 2010 |
1145 |
| The psychosocial issues of survivorship in breast cancer. |
Maher, Jane; Fenlon, Deborah |
Clinical report |
Jul 1, 2010 |
5804 |
| Papillary thyroid carcinoma presenting as an asymptomatic pelvic bone metastases. |
Siddiq, S.; I., I. Ahmad; Colloby, P. |
Case study |
Jul 1, 2010 |
1066 |
| Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. |
Marquez, Christina; Bair, Sarah M.; Smithberger, Erica; Cherpelis, Basil S.; Fenske, Neil Alan; Glas |
Report |
Jul 1, 2010 |
4192 |
| Merkel cell carcinoma: clinical characteristics, markers, staging and treatment. |
Lien, Mary H.; Baldwin, Brooke T.; Thareja, Sumeet K.; Fenske, Neil Alan |
Report |
Jul 1, 2010 |
4563 |
| Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer. |
|
Clinical report |
Jun 9, 2010 |
1863 |
| Aeterna Zentaris Reports Final Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine in the Treatment of Advanced Metastatic Colorectal Cancer. |
|
Clinical report |
Jun 8, 2010 |
1881 |
| Phase III Study Results Showed Eisai's Eribulin Mesylate Significantly Improved Overall Survival in Patients with Locally Recurrent or Metastatic Breast Cancer. |
|
Clinical report |
Jun 6, 2010 |
1254 |
| Phase III Study Results Showed Eisai's Eribulin Mesylate Significantly Improved Overall Survival in Patients With Locally Recurrent or Metastatic Breast Cancer. |
|
Clinical report |
Jun 6, 2010 |
1636 |
| New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential Advantages Over Standard of Care. |
|
|
Jun 5, 2010 |
3349 |
| Denosumab Demonstrated Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Prostate Cancer. |
|
|
Jun 5, 2010 |
2269 |
| Investigational Compound Ipilimumab Demonstrates Improved Overall Survival in Phase 3 Trial of Previously-Treated Patients with Metastatic Melanoma. |
|
Clinical report |
Jun 5, 2010 |
1321 |
| The Angeles Clinic and Research Institute Announces Investigational Compound Ipilimumab Demonstrates Improved Overall Survival in Phase 3 Trial of Previously-Treated Patients with Metastatic Melanoma. |
|
|
Jun 5, 2010 |
1122 |
| New AMG 479 Phase 2 Data Show Antitumor Activity in Patients With Metastatic Pancreatic Cancer. |
|
Clinical report |
Jun 4, 2010 |
1879 |
| Metastatic NSCLC Survival Doubled Using Functional Profiling to Select Drug Treatments. |
|
|
Jun 3, 2010 |
560 |
| Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review. |
Canil, Christina; Hotte, Sebastien; Mayhew, Linda A.; Waldron, Tricia S.; Winquist, Eric |
Clinical report |
Jun 1, 2010 |
4264 |
| 'Think outside the box' in treating anorexia. |
Wendling, Patrice |
|
Jun 1, 2010 |
979 |
| Study of GSK2132231A antigen-specific cancer immunotherapeutic in patients with inoperable metastatic cutaneous melanoma. |
|
Brief article |
Jun 1, 2010 |
110 |
| Complete lymph node dissection or observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinel lymphadenectomy. |
|
Brief article |
Jun 1, 2010 |
173 |
| TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. |
Puppa, Giacomo; Sonzogni, Angelica; Colombari, Romano; Pelosi, Giuseppe |
Report |
Jun 1, 2010 |
13259 |
| Cavities in the lung in oncology patients: imaging overview and differential diagnoses. |
Gill, Ritu R.; Matsusoka, Shin; Hatabu, Hiroto |
Report |
Jun 1, 2010 |
5411 |
| Tumor-Targeted Nanoparticle-based Gene Delivery Provides Evidence of Therapeutic Vaccination in Patients with Metastatic Cancer (ASCO 2010). |
|
|
May 24, 2010 |
479 |
| Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010). |
|
|
May 24, 2010 |
485 |
| Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously. |
|
Financial report |
May 20, 2010 |
882 |
| Cell Therapeutics Announces Agreement for Phase II Study of Pixantrone in Metastatic Breast Cancer. |
|
|
May 13, 2010 |
1176 |
| Epeius Biotechnologies Reports Major Clinical Advances: Noteworthy Clinical Case Studies in Cancer Gene Therapy. |
|
|
May 4, 2010 |
658 |
| Advaxis to Host Investigators Meeting for ADXS11-001 Cervix Cancer Trial in Mumbai, India. |
|
|
May 3, 2010 |
722 |
| Cervical and endometrial metastases of appendiceal goblet cell carcinoid. |
Pan, Zenggang; Repertinger, Susan; Leonard, Ronald; Bewtra, Chhanda; Gatalica, Zoran; Sharma, Poonam |
Case study |
May 1, 2010 |
2482 |
| Medivation and Astellas Announce Publication in The Lancet of Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients. |
|
|
Apr 14, 2010 |
1849 |
| ZIOPHARM Commences Oral Indibulin Phase I/II Trial in Breast Cancer -- at Memorial Sloan-Kettering Cancer Center --. |
|
|
Apr 8, 2010 |
1100 |
| LILLY (ELI) & COMPANY - Alimta Recommended in UK for Cancer Maintenance Therapy. |
|
|
Apr 1, 2010 |
1917 |
| PET-CT and breast cancer. |
Grant, Lee; Sharma, Bhuey |
Clinical report |
Apr 1, 2010 |
3397 |
| Neratinib, an irreversible erbB receptor tyrosine kinase inhibitor, in patients with advanced erbB2-positive breast cancer. |
Sharma, Anand; Jayanth, Akali |
|
Apr 1, 2010 |
579 |
| OSI Pharmaceuticals Announces That Tarceva[R] Received a Positive Opinion from Health Authorities in the European Union for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer. |
|
|
Mar 19, 2010 |
989 |
| Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refractory Prostate Cancer. |
|
|
Mar 3, 2010 |
1509 |
| Radioiodine therapy in skeletal metastases from well-differentiated thyroid cancer: a Johannesburg experience. |
Perumal, Nalini Sindy; Heben, Mboyo-Di-Tamba; Willy Vangu |
Report |
Mar 1, 2010 |
2567 |
| Distant metastasis more likely in obese breast cancer patients. |
Bates, Betsy |
|
Mar 1, 2010 |
508 |
| Dasatinib in treating patients with unresectable or metastatic squamous cell skin cancer. |
|
Brief article |
Mar 1, 2010 |
157 |
| Hypnosis may help control pain among metastatic breast cancer patients. |
|
Clinical report |
Feb 27, 2010 |
249 |
| Provectus' PV-10 and Radiotherapy Featured in Peer Reviewed Journal. |
|
|
Feb 9, 2010 |
746 |
| Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases. |
|
|
Feb 8, 2010 |
2535 |
| The value of specialty oncology drugs. |
Goldman, Dana P.; Jena, Anupam B.; Lakdawalla, Darius N.; Malin, Jennifer L.; Malkin, Jesse D.; Sun, |
Report |
Feb 1, 2010 |
6861 |
| The management of seizures in brain tumor patients. |
Smith, Kristen Catherine |
Report |
Feb 1, 2010 |
8532 |
| Sorafenib-Induced psoriasiform eruption in a patient with metastatic thyroid carcinoma. |
Diamantis, Melissa L.; Chon, Susan Y. |
Case study |
Feb 1, 2010 |
1466 |
| Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma. |
Youssif, Tamer Abou; Tanguay, Simon |
Report |
Feb 1, 2010 |
1857 |
| Cytoreductive nephrectomy: a treatment of the past. |
Venner, Peter |
Report |
Feb 1, 2010 |
1748 |
| Diagnosis of metastatic neoplasms: an immunohistochemical approach. |
Krishna, Murli |
Report |
Feb 1, 2010 |
6282 |
| Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. |
Monzon, Federico A.; Koen, Tracie J. |
Report |
Feb 1, 2010 |
8093 |
| Radio frequency ablation effectively reduces pain from bone metastases. |
|
|
Jan 6, 2010 |
374 |
| Enzon Opens a Phase 2 Study of PEG-SN38 for Metastatic Breast Cancer. |
|
|
Jan 6, 2010 |
559 |
| Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. |
Papavasiliou, Pavlos; Fisher, Tammy; Kuhn, Joseph; Nemunaitis, John; Lamont, Jeffrey |
Clinical report |
Jan 1, 2010 |
2891 |
| Radiologic findings after successful chemoradiation for nasopharyngeal cancer with skull base erosion. |
Ampil, Federico; Sangster, Guillermo; Mills, Glenn; Nathan, Cherie Ann; Lian, Timothy; Hall, Andrew |
Case study |
Jan 1, 2010 |
1632 |
| Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing. |
|
|
Dec 28, 2009 |
690 |
| Oncology implications for exercise and rehabilitation. |
Billek-Sawhney, Barbara; Wells, Chris L. |
Report |
Dec 22, 2009 |
6050 |
| ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas. |
|
|
Dec 17, 2009 |
1018 |
| OSI Pharmaceuticals Announces Conference Call on ODAC Review of Tarceva[R] for Use as First-line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer. |
|
|
Dec 16, 2009 |
357 |
| Primary sinonasal malignant melanoma: a clinicopathologic and prognostic study. |
Kumar, Sudesh; Gupta, Ashok K.; Yadav, Budhi S.; Ghoshal, Sushmita |
Clinical report |
Dec 1, 2009 |
2461 |
| Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy. |
Svatek, Robert S.; Siefker-Radtke, Arlene; Dinney, Colin P. |
Clinical report |
Dec 1, 2009 |
3028 |
| Surveillance strategies after definitive therapy of invasive bladder cancer. |
Cagiannos, Ilias; Morash, Christopher |
Report |
Dec 1, 2009 |
4724 |
| Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases. |
Guevremont, Catherine; Mija, Florin I.; Isbarn, Hendrik; Jeldres, Claudio; Lughezzani, Giovanni; Sun |
Case study |
Dec 1, 2009 |
1295 |
| Recent advances and future developments in breast cancer surgery. |
Cutress, Ramsey I. |
Report |
Dec 1, 2009 |
3620 |
| Sirtex Announces Creation of Centers of Excellence Program and Inaugural Honorees. |
|
|
Nov 23, 2009 |
601 |
| 'Fly paper' to capture circulating cancer cells created. |
|
|
Nov 19, 2009 |
371 |
| Genentech Submits Supplemental Applications to FDA for Avastin Combined with Commonly Used Chemotherapies for Women with Advanced Breast Cancer. |
|
|
Nov 17, 2009 |
1703 |
| Sarcomatoid chromophobe renal cell carcinoma with heterologous sarcomatoid elements: a case report and review of the literature. |
Quiroga-Garza, Gabriela; Khurana, Hema; Shen, Steven; Ayala, Alberto G.; Ro, Jae Y. |
Clinical report |
Nov 1, 2009 |
2156 |
| Newcastle disease virus as an oncolytic agent. |
Ravindra, P.V.; Tiwari, Ashok K.; Sharma, Bhaskar; Chauhan, R.S. |
Report |
Nov 1, 2009 |
5019 |
| NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment. |
|
|
Oct 27, 2009 |
625 |
| As Nation Focuses on Reforming Healthcare, Neurosurgeons Release the First Evidence-Based, Multidisciplinary Treatment Guidelines for Brain Metastases Patients. |
|
|
Oct 26, 2009 |
899 |
| Ipsen and Debiopharm Group Announce That Decapeptyl[R] (triptorelin embonate) 6-Month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer. |
|
|
Oct 13, 2009 |
1247 |
| Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial. |
|
|
Oct 8, 2009 |
789 |
| Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection. |
|
|
Oct 1, 2009 |
671 |
| PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations. |
Emmenegger, Urban; Ko, Yoo-Joung |
Clinical report |
Oct 1, 2009 |
1219 |
| The future is BRiTE. |
Stebbing, Justin; Windsor, Alastair; Cohen, Richard |
Clinical report |
Oct 1, 2009 |
2135 |
| 15th Congress of the European Cancer Organization and the 34th European Society for Medical Oncology multidisciplinary congress: GI update. |
Brown, Vanessa |
Clinical report |
Oct 1, 2009 |
1840 |
| Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. |
Guillen, Ponce; Carrato, Alfredo |
Clinical report |
Oct 1, 2009 |
1431 |
| The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer. |
Monzon, Federico A.; Ogino, Shuji; Hammond, M. Elizabeth H.; Hailing, Kevin C.; Bloom, Kenneth J.; N |
Disease/Disorder overview |
Oct 1, 2009 |
5791 |
| Plexxikon Announces First Patient Dosed in First of Two Pivotal Trials of PLX4032 for Metastatic Melanoma. |
|
|
Sep 29, 2009 |
1047 |
| Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer. |
|
|
Sep 24, 2009 |
2243 |
| Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer. |
|
|
Sep 22, 2009 |
2107 |
| Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients. |
|
|
Sep 22, 2009 |
2543 |
| Provectus Completes Treatment of All Patients in Phase 2 Trial of PV-10 for Metastatic Melanoma. |
|
|
Sep 21, 2009 |
716 |
| Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases. |
|
|
Sep 21, 2009 |
2604 |
| IntrinsiQ Study: Oncologists Overlook Maintenance Therapy Option - More Often than They Realize. |
|
Clinical report |
Sep 15, 2009 |
521 |
| Curis Announces GDC-0449 Phase I Clinical Data Published in New England Journal of Medicine. |
|
|
Sep 3, 2009 |
1663 |
| Resistance to hormone therapy in breast cancer. |
Hiscox, Stephen; Nicholson, Robert I. |
Report |
Sep 1, 2009 |
4410 |
| Chemosensitivity (and resistance) in breast cancer. |
Eccles, Bryony; Murray, Nick |
Report |
Sep 1, 2009 |
2738 |
| Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption. |
Barrett-Lee, Peter |
Brief article |
Sep 1, 2009 |
288 |
| Circulating tumor cells: seeing is believing. |
Fischer, Andrew H. |
Report |
Sep 1, 2009 |
2316 |
| Oestrogen treatment safe for some metastatic breast cancer patients. |
|
|
Aug 19, 2009 |
530 |
| Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer. |
|
|
Aug 18, 2009 |
1822 |
| Dasatinib in treating patients with unresectable or metastatic squamous cell skin cancer. |
|
|
Aug 1, 2009 |
160 |
| New advance in pancreatic cancer. |
Jurasunas, Serge |
Report |
Aug 1, 2009 |
3059 |
| Variation of monosomy 3 status within uveal melanoma. |
Schoenfield, Lynn; Pettay, James; Tubbs, Raymond R.; Singh, Arun D. |
Report |
Aug 1, 2009 |
2542 |
| Prognostic value of E-cadherin, [beta]-catenin, CD44v6, and HER2/neu in metastatic cutaneous adenocarcinoma. |
Pozdnyakova, Olga; Hoang, Mai M.P.; Dresser, Karen A.; Mahalingam, Meera |
Report |
Aug 1, 2009 |
3474 |
| Lymph node melanosis in a patient with metastatic melanoma of unknown primary. |
Malafronte, Patrick; Sorrells, Timothy |
Disease/Disorder overview |
Aug 1, 2009 |
1323 |
| Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia. |
|
|
Jul 28, 2009 |
725 |
| Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE[R] Vs. Taxol[R]. |
|
Clinical report |
Jul 14, 2009 |
1711 |
| "Endo-depression" in surgical patients: why surgeons may more effectively treat depression. |
Christodoulou, Irene |
Report |
Jul 1, 2009 |
3541 |
| Merck KGaA Initiates Phase III Study of Stimuvax in Breast Cancer. |
|
|
Jun 22, 2009 |
1112 |
| Abraxis Bioscience Launches ABRAXANE[R] in China for Women with Metastatic Breast Cancer. |
|
|
Jun 12, 2009 |
1801 |
| Emerging thyroid ca therapies show promise. |
Sullivan, Michele G. |
|
Jun 1, 2009 |
626 |
| Should we treat lung metastases from adenoid cystic carcinoma of the head and neck in asymptomatic patients? |
Syed, Irfan M.; Howard, David J. |
Report |
Jun 1, 2009 |
3384 |
| UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients. |
|
|
Jun 1, 2009 |
1565 |
| Plexxikon Announces PLX4032 Phase 1 Data Showing Objective Responses in Metastatic Melanoma Patients. |
|
|
Jun 1, 2009 |
1504 |
| Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients With Colorectal Cancer Liver Metastases who Have Exhausted Chemotherapy. |
|
|
Jun 1, 2009 |
873 |
| Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients with Colorectal Cancer Liver Metastases who have Exhausted Chemotherapy. |
|
|
Jun 1, 2009 |
874 |
| Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. |
Kim, Sangmin; Choi, Jae Hyuck; Lim, Hye In; Lee, Se-Kyung; Kim, Wan Wook; Kim, Jee Soo; Kim, Jung-Ha |
Report |
Jun 1, 2009 |
3739 |
| Challenges in breast pathology: new twists on old problems. |
Tavassoli, Fattaneh A. |
Report |
Jun 1, 2009 |
2398 |
| Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. |
Sahin, Aysegul A.; Guray, Merih; Hunt, Kelly K. |
Report |
Jun 1, 2009 |
7701 |
| Clear cell adenocarcinoma of the urinary bladder: a short review. |
Adeniran, Adebowale J.; Tamboli, Pheroze |
Disease/Disorder overview |
Jun 1, 2009 |
3168 |
| Psychotic illness in breast cancer. |
Sharma, Anand; Ngan, Sarah; Stebbing, Justin |
Report |
Jun 1, 2009 |
2810 |
| Evolution of multidisciplinary care for patients with metastatic colorectal cancer: the 'win-win' combination of surgery and chemotherapy. |
Adam, Rene; Gorden, D. Lee |
Clinical report |
Jun 1, 2009 |
988 |
| Results from Three Phase 2 Studies Reported a Two-Year Survival Rate Ranging from 30 to 42 Percent in Metastatic Melanoma Patients Treated with Ipilimumab (10 mg/kg). |
|
Clinical report |
May 31, 2009 |
1905 |
| Surgery not necessary for most metastatic colorectal cancer patients. |
|
|
May 31, 2009 |
353 |
| New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment. |
|
Clinical report |
May 29, 2009 |
1656 |
| Metastatic Colon Cancer: In a Randomized Phase II Clinical Study, Antineoplaston Therapy Doubled the 5-Year Survival Rate Following Curative Resection of Hepatic Metastases. |
|
Clinical report |
May 27, 2009 |
490 |
| New Study Results Published Compare ABRAXANE[R] to Taxotere[R]. |
|
|
May 27, 2009 |
2255 |
| Provectus Completes Patient Accrual in Phase 2 Trial of PV-10 for Metastatic Melanoma. |
|
|
May 14, 2009 |
715 |
| ZymoGenetics Reports Encouraging Preliminary Results from Phase 2 Study of IL-21 in Metastatic Melanoma Conducted by NCIC. |
|
|
May 13, 2009 |
566 |
| Endocyte Initiates Phase 1 Trial of EC0489 for Treatment of Refractory or Metastatic Solid Tumors. |
|
|
May 6, 2009 |
551 |
| Complete lymph node dissection of observation in treating patients with localized melanoma and sentinel node metastasis who have undergone sentinal lymphadenectomy. |
|
Brief article |
May 1, 2009 |
170 |
| Scientists find new laboratory test to target dangers of breast cancer spreading. |
|
|
Mar 25, 2009 |
371 |
| Biothera Receives Approval to Launch Two Phase II Lung Cancer Trials. |
|
|
Mar 12, 2009 |
445 |
| A case of non-small cell lung cancer and retrobulbar metastasis/Bilateral retrobulber metastazli kucuk hucreli disi akciger karsinomlu olgu. |
Varol, Yelda; Gunes, Ebru Yilmaz; Yuzuak, Murat; Guldaval, Filiz; Dereli, Sevket; Ozacar, Rifat |
Clinical report |
Mar 1, 2009 |
895 |
| On the path to recovery on the Gerson therapy from colon cancer with liver metastases. |
D'Anastasio, Tom; Gerson, Charlotte |
|
Mar 1, 2009 |
708 |
| The pathology and genetics of metastatic pancreatic cancer. |
Yachida, Shinichi; Iacobuzio-Donahue, Christine A. |
Report |
Mar 1, 2009 |
6873 |
| NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Castrate Resistant Prostate Cancer. |
|
|
Feb 11, 2009 |
605 |
| Algeta to Enroll US Patients Into Global Phase III ALSYMPCA Trial Following Successful End-of-Phase II Meeting With FDA. |
|
|
Feb 3, 2009 |
1160 |
| Synta Completes Enrollment of the Phase 3 SYMMETRYSM Trial of Elesclomol in Stage IV Metastatic Melanoma. |
|
|
Feb 2, 2009 |
1685 |
| Biothera Expands Metastatic Colorectal Cancer Trial. |
|
|
Jan 29, 2009 |
458 |
| Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer. |
|
Clinical report |
Jan 14, 2009 |
1567 |
| Hormone cuts down cancer risk; In association with the NHS. |
|
|
Jan 5, 2009 |
108 |
| New ways to care for people living lager with cancer: as survival rates climb for chronic forms of the disease, hospitals strive to make the experience easier on patients. |
Thrall, Terese Hudson |
|
Jan 1, 2009 |
2084 |
| Abraxis BioScience Launches Abraxane[R] in European Union. |
|
|
Dec 15, 2008 |
1300 |
| New Data Demonstrate Significant Improvement in Progression-Free Survival for Triple Negative Metastatic Breast Cancer Patients Treated with IXEMPRA[TM] Plus Capecitabine. |
|
Clinical report |
Dec 12, 2008 |
1744 |
| Two Studies Show Benefits of Removing Tumor Tissue in the Spine Prior to Adjuntive Treatments. |
|
|
Dec 1, 2008 |
1242 |
| Isolated thyroid metastasis of malignant melanoma with unknown primary origin/Primeri bilinmeyen malign melanomun izole tiroid metastazi. |
Karakurt, Feridun; Bavbek, Nukhet; Bayrak, Reyhan; Kargili, Ayse; Kasapoglu, Benan |
Case study |
Dec 1, 2008 |
1250 |
| Efficacy of cisplatin and vinorelbine in patients with metastatic non-small cell lung carcinoma/ Metastatik kucuk hucreli disi akciger karsinomlu hastalarda sisplatin ve vinorelbinin etkinligi. |
Yilmaz, Ufuk; Halilcolar, Huseyin; Yildirim, Yasemin; Yapicioglu, Sena; Unsal, Ipek; Mahlec, Ceyda |
Clinical report |
Dec 1, 2008 |
2750 |
| Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer. |
|
|
Nov 24, 2008 |
1285 |
| Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment. |
|
Clinical report |
Nov 19, 2008 |
1228 |
| NCCN Updates Guidelines for Colorectal Cancer. |
|
|
Nov 3, 2008 |
704 |
| Mary Ellen's story: recovery from stage IV metastatic melanoma. |
Childree, Bob |
|
Nov 1, 2008 |
2544 |
| Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment. |
|
Clinical report |
Oct 22, 2008 |
1502 |
| Elekta Announces Installation of Leksell Gamma Knife(R) Perfexion(TM) at Haukeland University Hospital in Norway. |
|
|
Oct 20, 2008 |
411 |
| Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures. |
|
|
Oct 15, 2008 |
603 |
| Metastatic disease is relatively common in cases of breast cancer. |
Gudgeon, Anne |
Report |
Oct 1, 2008 |
926 |
| Ipsen announces the filing of Decapeptyl(R) 6-month formulation for the treatment of locally advanced or metastatic prostate cancer in Europe. |
|
|
Sep 25, 2008 |
990 |
| ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer. |
|
|
Sep 19, 2008 |
2056 |
| New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status. |
|
|
Sep 16, 2008 |
590 |
| ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer. |
|
|
Sep 16, 2008 |
1841 |
| Updated Survival Data from Three Phase 2 Ipilimumab Studies Showed Almost Half of Previously Treated Metastatic Melanoma Patients Alive Beyond One Year. |
|
Clinical report |
Sep 15, 2008 |
1712 |
| Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal Cancer. |
|
|
Sep 12, 2008 |
715 |
| Study Published in New England Journal of Medicine Shows ERBITUX(R) Improved Survival in First-Line Recurrent And/Or Metastatic Head and Neck Cancer. |
|
|
Sep 10, 2008 |
1477 |
| Mastoiditis on MRI: fact or artifact? |
Meredith, James R.; Boyev, K. Paul |
Clinical report |
Sep 1, 2008 |
2502 |
| Prostatic carcinoma metastatic to the paranasal sinuses: a case report. |
Viswanatha, Borlingegowda |
Clinical report |
Sep 1, 2008 |
1293 |
| Circulating tumour cells as tumour markers. |
Jiao, Long; Apostolopoulos, Christos; Stebbing, Justin |
Report |
Sep 1, 2008 |
1795 |
| Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study. |
Petkar, Imran; Cunningham, David |
Report |
Sep 1, 2008 |
1911 |
| Protesters demand NHS treatment rethink. |
|
|
Aug 28, 2008 |
211 |
| Global Phase 3 Study of IMC-1121B in Metastatic Breast Cancer Commences. |
|
|
Aug 13, 2008 |
1078 |
| Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder. |
|
|
Jul 21, 2008 |
1000 |
| ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer. |
|
|
Jul 16, 2008 |
2133 |
